Cite
MLA Citation
Sean M. Smith et al.. “O2‐13‐04: Early Clinical Results and Preclinical Validation of the O‐Glcnacase (OGA) Inhibitor Mk‐8719 as a Novel Therapeutic for the Treatment of Tauopathies.” Alzheimer's & dementia, vol. 12, n.d., p. P261. http://access.bl.uk/ark:/81055/vdc_100102762723.0x000018